Insider Stock Trading History of Xie Lan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Xie Lan since year 2005. The trader's CIK number is 1555794. At the time of this reporting, Xie Lan is the VP Finance, China CFO of Sciclone Pharmaceuticals Inc . (stock ticker symbol SCLN). See this page for all insider trading activities at Sciclone Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Xie Lan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-13 SCLN Sciclone Pharmaceuticals Inc Option Ex 8,000 .00 0
2017-08-15 SCLN Sciclone Pharmaceuticals Inc Option Ex 10,000 .00 0
2017-08-16 SCLN Sciclone Pharmaceuticals Inc Sale 10,000 11.00 110,000
2017-06-12 SCLN Sciclone Pharmaceuticals Inc Option Ex 1,000 .00 0
2017-06-12 SCLN Sciclone Pharmaceuticals Inc Sale 1,000 10.75 10,750
2017-03-15 SCLN Sciclone Pharmaceuticals Inc Option Ex 1,000 .00 0
2017-03-16 SCLN Sciclone Pharmaceuticals Inc Sale 1,000 9.60 9,600
2016-08-12 SCLN Sciclone Pharmaceuticals Inc Sale 32,832 10.37 340,500
2016-08-12 SCLN Sciclone Pharmaceuticals Inc Option Ex 32,832 4.61 151,486
2015-12-03 SCLN Sciclone Pharmaceuticals Inc Option Ex 14,166 4.75 67,246
2015-12-03 SCLN Sciclone Pharmaceuticals Inc Sale 14,166 9.50 134,577
2015-05-15 SCLN Sciclone Pharmaceuticals Inc Option Ex 26,668 4.75 126,592
2015-05-15 SCLN Sciclone Pharmaceuticals Inc Sale 26,668 9.20 245,345
2014-09-02 SCLN Sciclone Pharmaceuticals Inc Sale 36,468 6.97 254,036
2014-09-02 SCLN Sciclone Pharmaceuticals Inc Option Ex 36,468 4.86 177,234
2013-08-14 SCLN Sciclone Pharmaceuticals Inc Option Ex 1,032 5.19 5,356

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Xie Lan (VP Finance, China CFO of Sciclone Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.